Dr. Mayersohn serves as Chief Strategy Officer in Shenox, which he co-founded in 2015. He also serves as the Chief Strategy Officer in GDB since 2017.
Dr. Mayersohn earned his Ph.D. from SUNY Buffalo Pharmacy. He is a Fellow of the American Society of Pharmaceutical Scientists, the Academy of Pharmacology, and the American Society of Clinical Pharmacology. He also served on the FDA Pharmacy Advisory Board; and Chairman of the Pharmacology Committee of the American Pharmacopeia.
Dr. Mayersohn is a professor in University of Arizona for over 40 years. He is an authoritative expert in the field of PK. He also served as an expert witness in pharma litigations. He is also experienced in IP matters.
Recommended Pipeline
—
Recommended News
—